Phase Ib proof-of-concept trial of ACH 3102 in patients with genotype 1a hepatitis C.
Phase of Trial: Phase I
Latest Information Update: 23 Apr 2013
At a glance
- Drugs Odalasvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacogenomic; Therapeutic Use
- 23 Apr 2013 Results reported at International Liver Congress 2013 at the 48th Annual Meeting of the European Association for the Study of the Liver (EASL), according to an Achillion media release.
- 03 Oct 2012 Status changed from recruiting to completed.
- 07 Aug 2012 New trial record